S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
pixel
pixel
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
pixel
pixel
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
pixel
pixel
S&P 500   3,870.29
DOW   31,391.52
QQQ   318.40
pixel
pixel
pixel
Log in
OTCMKTS:NSPX

Inspyr Therapeutics Short Interest Ratio and Short Volume

$0.01
0.00 (0.00 %)
(As of 03/2/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.01
Now: $0.01
$0.02
50-Day Range
$0.01
MA: $0.02
$0.04
52-Week Range
$0.00
Now: $0.01
$1.13
Volume6.86 million shs
Average Volume27.63 million shs
Market Capitalization$2.07 million
P/E RatioN/A
Dividend YieldN/A
Beta-16.55

Short Interest

Inspyr Therapeutics (OTCMKTS:NSPX) Short Interest Data

Current Short Volume158,400 shares
Previous Short Volume60,700 shares
Change Vs. Previous Month:+160.96%
Dollar Volume Sold Short$1,330.56
Short Interest Ratio / Days to Cover0.0
Last Record DateJanuary, 29 2021
Outstanding Shares150,000,000 shares
Percentage of Shares Shorted0.11%
Today's Trading Volume6,860,320 shares
Average Trading Volume27,632,910 shares
Today's Volume Vs. Average-75.17%

Short Interest Over Time


Inspyr Therapeutics (OTCMKTS:NSPX) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/29/2021158,400 shares $1,330.56 +161.0%N/A0 $0.01
1/15/202118,500 shares $129.50 No ChangeN/A0 $0.01
12/31/202018,500 shares $107.30 No ChangeN/A0 $0.01
12/15/202018,500 shares $162.80 No ChangeN/A0 $0.01
11/15/202072,400 shares $781.92 No ChangeN/A0 $0.01
9/15/202018,300 shares $183.00 No ChangeN/A0 $0.01
6/15/202017,200 shares $44.72 -64.7%N/A0 $0.00
5/29/202048,700 shares $165.58 No ChangeN/A0 $0.00
4/15/202013,400 shares $134.00 +396.3%N/A0 $0.01
3/31/20202,700 shares $27.00 +440.0%N/A0 $0.01
3/13/2020500 shares $2.00 No ChangeN/A0 $0.00
2/14/20204,800 shares $16.80 -91.2%N/A0 $0.00
1/31/202054,700 shares $164.10 No ChangeN/A0 $0.00
12/31/201956,200 shares $286.62 +462.0%N/A0.1 $0.01

Inspyr Therapeutics (OTCMKTS:NSPX) Short Interest FAQ

speech bubbles
speech bubbles











What is Inspyr Therapeutics' current short interest?

Short interest is the volume of Inspyr Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 29th, traders have sold 158,400 shares of NSPX short.

Is Inspyr Therapeutics' short interest increasing or decreasing?

Inspyr Therapeutics saw a increase in short interest during the month of January. As of January 29th, there was short interest totaling 158,400 shares, an increase of 161.0% from the previous total of 60,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Inspyr Therapeutics' short interest compare to its competitors?

0.00% of Inspyr Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Inspyr Therapeutics: Acura Pharmaceuticals, Inc. (0.00%), International Stem Cell Co. (0.00%), Intellipharmaceutics International Inc. (0.00%), Kaya Holdings, Inc. (0.00%), American Bio Medica Co. (0.00%), Cotinga Pharmaceuticals Inc. (0.00%), Amarantus BioScience Holdings, Inc. (0.00%), BriaCell Therapeutics Corp. (0.00%), Boston Therapeutics, Inc. (0.00%), and Immune Pharmaceuticals, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Aon Plc ($5.34 billion), Charter Communications, Inc. ($5.03 billion), ViacomCBS Inc. ($4.99 billion), DuPont de Nemours, Inc. ($4.72 billion), Analog Devices, Inc. ($4.57 billion), Snap Inc. ($3.87 billion), Moderna, Inc. ($3.58 billion), Futu Holdings Limited ($2.75 billion), Snowflake Inc. ($2.43 billion), and Palantir Technologies Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short Inspyr Therapeutics stock?

Short selling NSPX is an investing strategy that aims to generate trading profit from Inspyr Therapeutics as its price is falling. To short Inspyr Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Inspyr Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Inspyr Therapeutics?

A short squeeze for Inspyr Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NSPX, which in turn drives the price of the stock up even further.

How often is Inspyr Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NSPX, twice per month. The most recent reporting period available is January, 29 2021.



This page was last updated on 3/3/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.